WebMar 18, 2024 · Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2024 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference ... WebApr 6, 2024 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Fulcrum Therapeutics stock is Hold based on the current 1 sell rating, 4 hold ratings and 3 buy ratings for FULC. The average twelve-month price prediction for Fulcrum Therapeutics is $10.88 with a high price target of $21.00 and a low price target of $6.00 ...

FULC Price Target 2024 Fulcrum Therapeutics Analyst Ratings

WebJul 30, 2024 · Unfortunately FULC wasn't nearly as popular as these 5 stocks and hedge funds that were betting on FULC were disappointed as the stock returned -32.1% since the end of the first quarter (through 7 ... WebApr 11, 2024 · Fulcrum Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on genetically defined diseases with an initial focus on rare diseases. Fulcrum … elite shooting range bridgeville pa

FULC Stock Price Fulcrum Therapeutics Inc. Stock Quote (U.S.: …

WebFulcrum Therapeutics stock price target cut to $20 from $26 at Oppenheimer. Feb. 27, 2024 at 8:03 a.m. ET by Tomi Kilgore. WebInteractive Chart. Interactive Charts provide the most advanced and flexible platform for analyzing historical data, with over 100 customizable studies, drawing tools, custom … WebApr 5, 2024 · FULC Fulcrum Therapeutics Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of … forbes insurance agency morgantown pa